New Genomic Data-Sharing Efforts Aim to Bridge Pharma's Revenue-Innovation Gap
May 25, 2011
New Genomic Data-Sharing Efforts Aim to Bridge Pharma's Revenue-Innovation Gap
Efforts spearheaded by Sage Bionetworks and Genetic Alliance hope to encourage drug developers to share precompetitive genomic data from the comparator arms of drug trials and to give study participants more control over their own data generated in clinical investigations.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- With New BRCA Testing Options, Patient Groups Advise Women to Speak to Genetics Expert, Share Reports
June 19, 2013 / Pharmacogenomics Reporter - GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor - Scripps Study Highlights Protein Sulfenylation as Regulator of EGFR Activity, Potential Drug Target
December 16, 2011 / ProteoMonitor - Cellzome Snags More Than $3.1M in Grants for EU-, UK-Sponsored Research Initiatives
December 9, 2011 / ProteoMonitor - As More Patients Gain Knowledge of Genetic Makeup, FDA Warns Against Biased Personalized Rx Trials
November 2, 2011 / Pharmacogenomics Reporter